Healthcare
CareRx Corporation(CHHHF)
Live Price
Offline$2.31
+0.00% today
1Y Change
+5.46%
Window
Jun 25, 2025 โ Jun 22, 2026
- Market Cap
- $230.00M
- Revenue Growth
- +0.9%
- EPS Growth
- +647.4%
- Dividend Yield
- 1.6%
Coverage: 252 bars ยท Jun 25, 2025 โ Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
CareRx Corporation (CHHHF) is a Healthcare stock with a market cap of $230.00M and listed on OTC. The stock last traded around $2.31 and up 5.5% across the available one-year price window (Jun 25, 2025 โ Jun 22, 2026). Baseline metrics include revenue growth of +0.9%, EPS growth of +647.4%, a dividend yield of 1.6%. What stands out right now is revenue +0.9%, EPS +647.4%, free cash flow -26.6% with operating margin 2.9% and ROIC 5.4%. The dividend is present but secondary, with a yield around 1.6%. Valuation is more restrained than many high-expectation growth names at P/E 8.8 and price/sales 0.6. Stock Foundry combines CHHHF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+0.9% vs +7.6% peer median
Operating Margin
Below sector median
+2.9% vs +19.4% peer median
P/E
Below sector median
8.8 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 7, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +0.9% and EPS at +647.4%, with operating margin around 2.9%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 1.6%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -3.4% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 7, 2026 | โ | +0.0% | -4.0% | -13.5% |
2026 Mar 4, 2026 | +1379.4% | +0.0% | -6.1% | -4.7% |
2025 Nov 3, 2025 | -24.4% | +0.0% | +0.0% | -2.7% |
Benchmark Edge
CHHHF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CHHHF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CHHHF Max Drawdown
-20.07%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CHHHF and SPY.
Company Overview
CareRx Corporation
OTC
CareRx Corporation is a leading provider of specialty pharmacy services, operating primarily within the Canadian healthcare sector. The company's primary function is to deliver comprehensive pharmacy solutions tailored to the needs of senior living communities, long-term care homes, and other institutional clients. One of CareRx Corporation's key features is its focus on medication management, offering services such as blister packaging, automated dispensing systems, and medication review, which contribute to enhanced patient care and safety. CareRx plays a significant role in the healthcare ecosystem by ensuring that its services meet the complex requirements of an aging population, which places immense demand on medication adherence and comprehensive pharmaceutical care. Its operations help streamline the supply chain and clinical management processes for healthcare facilities, enhancing efficiency and reducing errors. By leveraging advanced technology and a network of pharmacies, CareRx Corporation maintains its market significance through continuous innovation and adaptation to the evolving healthcare landscape, essentially contributing to better health outcomes for Canadian seniors.
- Leadership
- Mr. Puneet Khanna
- Employees
- 1.4k
- Street Address
- 320 Bay Street, Suite 1200
- Mailing
- Toronto, ON, M5H 4A6
- Region
- Toronto, ON, Canada
- Last Updated
- May 7, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 8.8
- EV/EBITDA
- 10.2
- Price/Sales
- 0.6
- Price/Book
- 2.1
Growth
- Revenue
- +0.9%
- EPS
- +647.4%
- Free Cash Flow
- -26.6%
Profitability
- Gross Margin
- 27.5%
- Operating Margin
- 2.9%
- Net Margin
- 7.1%
- ROE
- 28.2%
- ROIC
- 5.4%
Balance Sheet
- Debt/Equity
- 0.71
- Current Ratio
- 1.06
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.